Advertisement
Differences in pace of hemodynamic change signal need for sex-specific management
Details released from the trial halted due to excessive thromboembolic events
Cleveland Clinic study finds expected STS risk no longer reflects current outcomes
Study offers guidance on an increasingly common presentation
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
State-of-the-art review gives guidance for populations not addressed in TAVR trials
Observational findings over 5+ years of follow-up argue for caution in this population
Investigators urge caution until more data accrue
Zero cases of structural valve deterioration through latest follow-up
Our experts recap the most notable changes and developments
Database analysis sets stage for a multicenter trial assessing TAVR’s potential role
Advertisement
Advertisement